Call for Abstract

5th World Congress on Cancer Therapy, will be organized around the theme “Innovations and Novel Approaches in Diagnosis and Treatment of different Cancers”

Cancer Therapy 2015 is comprised of 27 tracks and 70 sessions designed to offer comprehensive sessions that address current issues in Cancer Therapy 2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Biomarkers in Cancer Research
  • Track 1-2Biomarkers in Medicine
  • Track 1-3Biomarkers in Cancer Medicine
  • Track 1-4Risk assessment, Diagnosis
  • Track 1-5Prognosis and treatment predictions
  • Track 1-6Pharmacodynamics and pharmacokinetics
  • Track 1-7Molecular cancer biomarkers
  • Track 2-1CAR T-Cell Therapy
  • Track 2-2Oncolytic viral therapies
  • Track 2-3Gene-therapy
  • Track 2-4Adoptive T-Cell transfer
  • Track 3-1Cancer Microenvironment
  • Track 3-2Chemo Drugs
  • Track 3-3Stealth Nanoparticles and Tumor Penetrating Peptides
  • Track 3-4Vector/Host Interaction
  • Track 3-5New Nanomaterials
  • Track 3-6Imaging and Theranostics
  • Track 3-7Early Diagnosis and Imaging
  • Track 3-8Advances in Nanotechnology
  • Track 4-1Cancer in China
  • Track 4-2Cancer in Japan
  • Track 4-3Cancer in Sweden
  • Track 4-4Cancer in Malaysia
  • Track 4-5Cancer in Singapore
  • Track 4-6Cancer in America
  • Track 4-7Cancer in Canada
  • Track 4-8Cancer in USA
  • Track 5-1Clinical Toxicology
  • Track 5-2Pharmacokinetics
  • Track 5-3Pharmacodynamics
  • Track 5-4Drug interactions
  • Track 19-1 Treatment strategies
  • Track 19-2Adverse effects
  • Track 19-3Limitations
  • Track 19-4Novel and experimental approaches
  • Track 20-1Nutrition and Supplements
  • Track 20-2Diet and exercise
  • Track 20-3Cancer and Environment
  • Track 21-1Alternative Medical Systems
  • Track 21-2Mind-Body Methods
  • Track 21-3Nutritional Methods
  • Track 21-4Pharmacologic and Biologic Treatments
  • Track 22-1Cancer Genomics and Systems Biology
  • Track 22-2tumor immunology and immune therapy
  • Track 22-3Molecular and Cellular Oncology
  • Track 22-4Cancer stem cells
  • Track 23-1Brain, Bladder, Breast, Blood, Bone, Oral, Throat Cancer
  • Track 23-2Cervical, Colorectal, Kidney, Liver, Thyroid, Esophageal Cancer
  • Track 23-3Lung, Ovarian, Pancreatic, Prostate, Uterine (Endometrial) Cancer
  • Track 23-4Multiple Myeloma, Skin Cancer, Leukemia
  • Track 24-1Biomarkers in cancer detection
  • Track 24-2Targeting Protein involving DNA
  • Track 24-3Cancer Epidemiology
  • Track 24-4Stem cell research
  • Track 25-1Drugs and mechanism
  • Track 25-2Therapeutic antibodies & cancer vaccines
  • Track 25-3Novel drug delivery system & cancer drug designing
  • Track 25-4Nanotechnology in cancer drugs
  • Track 25-5Anticancer drugs in global market: economy & their cost effectiveness
  • Track 25-6Functional genomics in drug discovery & development
  • Track 26-1Revisiting tumor metabolism
  • Track 26-2Telomerase: A target for cancer therapeutics
  • Track 26-3Clinical and potential applications of metabolomics in oncology
  • Track 26-4Molecular cancer therapeutics
  • Track 26-5Metabolomics in novel biomarker discovery
  • Track 27-1 Radiotherapy and chemotherapy
  • Track 27-2 Molecular-targeted therapies
  • Track 27-3Cancer: Gene expression and protein profiling; Surgery and laparoscopy
  • Track 27-4Hormone replacement therapy
  • Track 27-5cancer metabolism